Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-11-17

Clinical Trial Update: A Study to Learn How Different Forms of the Study Medicine Called PF 08049820 Are Taken up Into the Bloodstream in Healthy Adults [Phase 1]

View source ↗

Summary

A Phase 1 pharmacokinetic study to assess how different forms of PF 08049820 are absorbed into the bloodstream in healthy adults, with Atopic Dermatitis listed …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PF-08049820

Snippet

Sponsor: Pfizer | Conditions: Atopic Dermatitis | Phase 1 | Status: COMPLETED